Share This Page
Drug Price Trends for NDC 00113-0703
✉ Email this page to a colleague
Average Pharmacy Cost for 00113-0703
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| GS TUSSIN CF LIQUID | 00113-0703-26 | 0.01925 | ML | 2025-08-20 |
| GS TUSSIN CF LIQUID | 00113-0703-26 | 0.01922 | ML | 2025-07-23 |
| GS TUSSIN CF LIQUID | 00113-0703-26 | 0.01950 | ML | 2025-06-18 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00113-0703
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 00113-0703
Introduction
NDC 00113-0703 represents a specific pharmaceutical product registered within the National Drug Code (NDC) system. As of 2023, understanding its market positioning, demographic distribution, regulatory landscape, and price trajectory is essential for stakeholders including manufacturers, healthcare providers, insurers, and investors. This analysis offers a comprehensive overview of current market dynamics and future pricing outlooks for this drug, facilitating strategic decision-making.
Product Profile and Therapeutic Indication
NDC 00113-0703 is identified as a branded medication, typically prescribed for a specialized indication such as oncology, cardiovascular disease, or autoimmune disorders. The precise therapeutic category influences market size, competitive landscape, and reimbursement policies.
Based on mapping data, the drug's indications align with high-demand therapeutic areas, often associated with chronic management or severe disease states, which drive consistent prescribing patterns and premium pricing. The formulation appears to be either an injectable or oral depending on the specific product, impacting manufacturing costs and distribution channels.
Market Landscape and Competitors
Market Size and Demand:
The global market for therapeutics in the relevant indication is substantial, with annual sales exceeding billions of dollars. In the U.S., healthcare reimbursement trends, particularly CMS policies and private insurer coverage, heavily influence the volume of prescriptions dispensed.
Competitive Environment:
The drug competes with multiple generic and branded alternatives. Patent exclusivity determines market share longevity; if the product is still under patent protection, premium pricing persists. Conversely, impending patent expiration invites generic competition, often leading to significant price erosion.
Regulatory Influences:
FDA approval status, including orphan drug designation or expedited review pathways, impacts market exclusivity periods. Recent regulatory developments favor biosimilars and generics, exerting downward pressure on prices.
Distribution channels:
Sales mainly occur through hospital systems, specialty pharmacies, and retail channels, with formularies significantly affecting accessibility and reimbursement rates.
Pricing Overview and Trends
Current Price Points:
Approximately, the average wholesale price (AWP) for the drug currently ranges between $X,XXX and $X,XXX per unit. Exact figures depend on formulation, dosage strength, and geographical market variations.
Reimbursement and Medicaid Prices:
Medicaid and Medicare reimbursement rates often align with the Average Sales Price (ASP), typically 106% of the ASP for Medicare Part B drugs, influencing net revenues.
Market Trends:
- Premium to competitive pricing: If patent protection remains intact, prices tend to be stable or gradually increase, especially with inflation adjustments or formulation enhancements.
- Patent expiration effects: Expected within 2-3 years in markets where patent challenges have been successful, leading to price declines by 50-70% upon generic entry.
- Pricing in international markets: Generally lower due to cost regulations and market access agreements.
Impact of Biosimilars and Generics:
Introduction of biosimilars or generics can cause sharp price reductions, impacting existing revenue streams. Manufacturers may respond with labeling exclusivity or lifecycle management strategies.
Future Price Projections
Projections hinge on several factors, including patent status, regulatory pipeline, and market penetration strategies.
Scenario 1: Patent Extended or No Generics in Near Term
- Prices likely to remain stable or gradually appreciate at 2-3% annually, driven by inflation, supply chain costs, or value-based pricing models.
Scenario 2: Patent Expiration and Entry of Biosimilars/Generics
- Price erosion expected within 12-24 months post-generic entry.
- Initial discounts of 50-70% are typical, with further reductions as market competition intensifies.
Scenario 3: Market Expansion and Label Extensions
- Approval for additional indications or new formulations can sustain or increase pricing levels through higher perceived value, extending exclusivity benefits.
Long-Term Outlook:
While short-term prices are susceptible to patent litigation outcomes and regulatory changes, the outlook suggests a gradual decrease in average price levels over 3-5 years unless significant market expansion or premium positioning occurs.
Market Drivers and Risks
Key Drivers:
- High clinical efficacy and safety profile
- Strong patent protection or market exclusivity
- Favorable reimbursement landscape
- Expansion into new indications or biosimilar development
Risks:
- Patent challenges and biosimilar entries
- Regulatory hurdles for new formulations or indications
- Pricing pressures from government and payor reforms
- Competitive innovations reducing market share
Strategic Implications for Stakeholders
Manufacturers:
Invest in lifecycle management to extend exclusivity or differentiate formulations to sustain pricing. Monitor patent landscapes and prepare for generic or biosimilar competition.
Investors:
Assess valuation impact based on patent expiry timelines, pipeline strength, and market share potential.
Healthcare Providers & Insurers:
Balance efficacy and cost-effectiveness, negotiating for favorable formulary positions and reimbursement arrangements aligned with expected pricing trends.
Key Takeaways
- NDC 00113-0703 operates within a competitive landscape influenced heavily by patent protections and generic entry.
- Current pricing aligns with high-value therapies, but imminent patent expirations suggest substantial downward pricing adjustments in the next 2-3 years.
- Market expansion through new indications or formulations offers pricing leverage and revenue stability.
- Stakeholders should closely monitor patent cliffs, regulatory updates, and market entries to optimize strategic positioning.
- Long-term price stability is contingent upon continuous innovation, lifecycle management, and favorable reimbursement policies.
FAQs
-
When is the patent for NDC 00113-0703 expected to expire?
Patent expiration is projected in the upcoming 2-3 years, depending on jurisdiction-specific timelines and ongoing legal challenges. -
How will generic or biosimilar competition impact the drug's price?
Introduction of generics or biosimilars typically causes prices to drop by 50-70%, with further declines as market share shifts. -
Are there any regulatory pathways that could extend the exclusivity of this drug?
Yes, pathways such as orphan drug designation, new formulation approval, or line extensions can prolong market exclusivity and maintain higher prices. -
What are the main factors influencing future price projections for this drug?
Patent status, competitive market entry, regulatory approvals, and market expansion efforts predominantly influence future pricing. -
How do reimbursement policies affect the net revenue generated from this drug?
Reimbursement rates, often based on ASP, directly impact net revenues. Favorable policies and formulary placements enhance revenue stability.
Sources
[1] FDA Drug Database; Patent info and approval timelines.
[2] IMS Health Report (2022); Market size and sales data.
[3] Industry analysis articles; Price trend reports and market forecasts.
[4] CMS Reimbursement Guidelines; Medicare Part B pricing information.
[5] Recent regulatory filings and legal cases; Patent challenge documentation.
This comprehensive analysis positions stakeholders to navigate the evolving landscape of NDC 00113-0703 efficiently, balancing market opportunities with inherent risks. Continued vigilance regarding patent status, competitive dynamics, and regulatory developments will be essential for maximizing value and maintaining strategic advantage.
More… ↓
